THORN RUN PARTNERS

Lobbying for ARDELYX, INC. · Pharmaceutical manufacturer

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 18, 2026

Lobbying activity 1

Health Issues

Issues related to Medicare ESRD benefit and chronic kidney disease management. Most-Favored-Nation (MFN) issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.